Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of vascular tree | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of CYP1A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 90% | 2570.77 | 203 / 226 | 56% | 49.19 | 226 / 406 |
skin | 56% | 973.78 | 1004 / 1809 | 50% | 3.04 | 235 / 472 |
bladder | 62% | 1147.67 | 13 / 21 | 27% | 114.71 | 137 / 504 |
breast | 67% | 1821.61 | 309 / 459 | 4% | 0.28 | 50 / 1118 |
adipose | 63% | 1911.69 | 753 / 1204 | 0% | 0 | 0 / 0 |
lung | 41% | 1505.45 | 236 / 578 | 9% | 3.64 | 103 / 1155 |
blood vessel | 48% | 604.77 | 637 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 31% | 227.49 | 443 / 1445 | 10% | 5.45 | 19 / 183 |
uterus | 31% | 153.89 | 52 / 170 | 7% | 8.52 | 33 / 459 |
kidney | 28% | 148.73 | 25 / 89 | 8% | 0.91 | 73 / 901 |
intestine | 27% | 213.15 | 260 / 966 | 7% | 0.61 | 38 / 527 |
muscle | 32% | 254.00 | 253 / 803 | 0% | 0 | 0 / 0 |
thymus | 27% | 263.39 | 176 / 653 | 3% | 0.09 | 17 / 605 |
prostate | 15% | 70.42 | 37 / 245 | 15% | 0.88 | 73 / 502 |
stomach | 18% | 189.40 | 63 / 359 | 6% | 0.35 | 18 / 286 |
heart | 19% | 358.58 | 163 / 861 | 0% | 0 | 0 / 0 |
ovary | 13% | 54.54 | 23 / 180 | 6% | 0.18 | 26 / 430 |
brain | 8% | 13.45 | 211 / 2642 | 9% | 0.14 | 64 / 705 |
peripheral blood | 17% | 71.21 | 154 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.64 | 4 / 29 |
pancreas | 4% | 17.70 | 12 / 328 | 8% | 10.07 | 15 / 178 |
adrenal gland | 5% | 70.06 | 13 / 258 | 5% | 0.06 | 11 / 230 |
spleen | 2% | 3.68 | 5 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010041 | Biological process | response to iron(III) ion |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0009804 | Biological process | coumarin metabolic process |
GO_0009624 | Biological process | response to nematode |
GO_0009692 | Biological process | ethylene metabolic process |
GO_0035902 | Biological process | response to immobilization stress |
GO_0060137 | Biological process | maternal process involved in parturition |
GO_0019341 | Biological process | dibenzo-p-dioxin catabolic process |
GO_0033189 | Biological process | response to vitamin A |
GO_1904681 | Biological process | response to 3-methylcholanthrene |
GO_0046685 | Biological process | response to arsenic-containing substance |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0006694 | Biological process | steroid biosynthetic process |
GO_0006778 | Biological process | porphyrin-containing compound metabolic process |
GO_0042904 | Biological process | 9-cis-retinoic acid biosynthetic process |
GO_0097267 | Biological process | omega-hydroxylase P450 pathway |
GO_0042359 | Biological process | vitamin D metabolic process |
GO_1900087 | Biological process | positive regulation of G1/S transition of mitotic cell cycle |
GO_0048771 | Biological process | tissue remodeling |
GO_0019373 | Biological process | epoxygenase P450 pathway |
GO_0009812 | Biological process | flavonoid metabolic process |
GO_0055093 | Biological process | response to hyperoxia |
GO_0071280 | Biological process | cellular response to copper ion |
GO_0001666 | Biological process | response to hypoxia |
GO_0001676 | Biological process | long-chain fatty acid metabolic process |
GO_0050665 | Biological process | hydrogen peroxide biosynthetic process |
GO_0009635 | Biological process | response to herbicide |
GO_0002933 | Biological process | lipid hydroxylation |
GO_0042572 | Biological process | retinol metabolic process |
GO_0048565 | Biological process | digestive tract development |
GO_0008210 | Biological process | estrogen metabolic process |
GO_0042759 | Biological process | long-chain fatty acid biosynthetic process |
GO_0043010 | Biological process | camera-type eye development |
GO_0017143 | Biological process | insecticide metabolic process |
GO_0046209 | Biological process | nitric oxide metabolic process |
GO_0032094 | Biological process | response to food |
GO_0008202 | Biological process | steroid metabolic process |
GO_0070365 | Biological process | hepatocyte differentiation |
GO_0071407 | Biological process | cellular response to organic cyclic compound |
GO_0009308 | Biological process | amine metabolic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0019899 | Molecular function | enzyme binding |
GO_0016679 | Molecular function | oxidoreductase activity, acting on diphenols and related substances as donors |
GO_0032451 | Molecular function | demethylase activity |
GO_0070330 | Molecular function | aromatase activity |
GO_0051879 | Molecular function | Hsp90 protein binding |
GO_0101020 | Molecular function | estrogen 16-alpha-hydroxylase activity |
GO_0120319 | Molecular function | long-chain fatty acid omega-1 hydroxylase activity |
GO_0019825 | Molecular function | oxygen binding |
GO_0008391 | Molecular function | arachidonic acid monooxygenase activity |
GO_0016491 | Molecular function | oxidoreductase activity |
GO_0004497 | Molecular function | monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0020037 | Molecular function | heme binding |
GO_0030544 | Molecular function | Hsp70 protein binding |
GO_0102033 | Molecular function | long-chain fatty acid omega-hydroxylase activity |
GO_0106256 | Molecular function | hydroperoxy icosatetraenoate dehydratase activity |
GO_0016711 | Molecular function | flavonoid 3'-monooxygenase activity |
GO_0005515 | Molecular function | protein binding |
GO_0070576 | Molecular function | vitamin D 24-hydroxylase activity |
GO_0101021 | Molecular function | estrogen 2-hydroxylase activity |
Gene name | CYP1A1 |
Protein name | Cytochrome P450 1A (EC 1.14.14.1) Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) |
Synonyms | hCG_40803 |
Description | FUNCTION: Cytochromes P450 are a group of heme-thiolate monooxygenases. They oxidize a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. . FUNCTION: Cytochromes P450 are a group of heme-thiolate monooxygenases. They oxidize a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. . FUNCTION: Cytochromes P450 are a group of heme-thiolate monooxygenases. They oxidize a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. . FUNCTION: Cytochromes P450 are a group of heme-thiolate monooxygenases. They oxidize a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. . FUNCTION: Cytochromes P450 are a group of heme-thiolate monooxygenases. They oxidize a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. . FUNCTION: A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) . Catalyzes the hydroxylation of carbon-hydrogen bonds. Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2, as well as D-ring hydroxylated E1 and E2 at the C15-alpha and C16-alpha positions . Displays different regioselectivities for polyunsaturated fatty acids (PUFA) hydroxylation . Catalyzes the epoxidation of double bonds of certain PUFA . Converts arachidonic acid toward epoxyeicosatrienoic acid (EET) regioisomers, 8,9-, 11,12-, and 14,15-EET, that function as lipid mediators in the vascular system . Displays an absolute stereoselectivity in the epoxidation of eicosapentaenoic acid (EPA) producing the 17(R),18(S) enantiomer . May play an important role in all-trans retinoic acid biosynthesis in extrahepatic tissues. Catalyzes two successive oxidative transformation of all-trans retinol to all-trans retinal and then to the active form all-trans retinoic acid . May also participate in eicosanoids metabolism by converting hydroperoxide species into oxo metabolites (lipoxygenase-like reaction, NADPH-independent) . . FUNCTION: Cytochromes P450 are a group of heme-thiolate monooxygenases. They oxidize a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. . FUNCTION: Cytochromes P450 are a group of heme-thiolate monooxygenases. They oxidize a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. . |
Accessions | ENST00000395048.6 [P04798-1] ENST00000566503.1 P04798 Q0VHD5 Q5J9B1 A4F3V8 A4F4K3 ENST00000564596.5 [P04798-3] ENST00000567032.5 [P04798-1] ENST00000379727.8 [P04798-1] E7EMT5 A4F4K4 ENST00000562201.5 [P04798-2] ENST00000617691.4 ENST00000569630.5 [P04798-2] ENST00000395049.8 A0N0X8 |